Sarah Bezzaoucha
Hôpital Maisonneuve-Rosemont
11 Papers
31 Citations
Sarah Bezzaoucha is an academic researcher from Hôpital Maisonneuve-Rosemont. The author has contributed to research in topics: Internal medicine & Hyperparathyroidism. The author has an hindex of 5, co-authored 9 publications. Previous affiliations of Sarah Bezzaoucha include Université de Montréal.
Chat about Author
Papers
Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients
Sandrine Rauscher,Jean-Philippe Lafrance,Vincent Pichette,Robert Bell,Katherine Desforges,Laurence Lepage,Georges Ouellet,Denis Ouimet,Martine Leblanc,Caroline Lamarche,Sarah Bezzaoucha,Michel Vallée +11 more
TL;DR: Calcitriol in equal dosage is more effective than alfacalcidol in lowering serum PTH level in chronic hemodialysis patients, suggesting that calcitriol may be the optimal active vitamin D3 for the treatment of SHPT in Chronic hemodialsysis patients.
10
Retrospective Study Looking at Cinacalcet in the Management of Hyperparathyroidism after Kidney Transplantation.
Habib Mawad,Hugues Bouchard,Duy Tran,Denis Ouimet,Jean-Philippe Lafrance,Robert Bell,Sarah Bezzaoucha,Anne Boucher,Suzon Collette,Vincent Pichette,Lynne Senécal,Michel Vallée +11 more
TL;DR: Cinacalcet appears to be an effective treatment of hypercalcemic hyperparathyroidism in kidney transplant recipients and further studies are needed to evaluate safety and long-term benefits.
Hemodialysis effects on phenytoin pharmacokinetics
Sarah Bezzaoucha,Amine Merghoub,Caroline Lamarche,Vincent Pichette,Jean-Philippe Lafrance,Louis-Philippe Laurin,Michel Vallée,Robert Robitaille,Martine Leblanc,Robert Bell,Robert Bell +10 more
TL;DR: The effect of hemodialysis on plasma protein binding of phenytoin and its impact on pheny toin plasma concentrations was assessed by measuring phenyToin serum concentrations in ten patients on phenYtoin maintenance therapy for epilepsy.
7
The effect of lanthanum carbonate on metabolic acidosis in patients with chronic kidney disease stage IV, V and V-D
William Beaubien-Souligny,Sarah Bezzaoucha,Vincent Pichette,Jean-Philippe Lafrance,Robert Bell,Caroline Lamarche,Denis Ouimet,Michel Vallée +7 more
TL;DR: In this study, lanthanum carbonate introduction increased serum bicarbonate concentration in a small sample of CKD IV–V patients and in patients on dialysis.
4